Features of Blood Clotting on Thromboelastography in Hospitalized Patients With Cirrhosis.

Features of Blood Clotting on Thromboelastography in Hospitalized Patients With Cirrhosis.
复制标题

DOI:
10.1016/j.amjmed.2020.04.029
复制
发表时间:
2020-12
期刊:
The American journal of medicine
影响因子:
--
通讯作者:
Orman ES
Orman ES
中科院分区:
其他
文献类型:
--
作者:
Shamseddeen H;Patidar KR;Ghabril M;Desai AP;Nephew L;Kuehl S;Chalasani N;Orman ES

文献摘要

参考文献

被引文献

相似文献

Thromboelastography (TEG) provides a global assessment of hemostasis and may have value for patients with cirrhosis who have multiple hemostatic defects. We sought to examine the characteristics of TEG in hospitalized patients with cirrhosis and its relationship with outcomes. We performed a cohort study of all adults with cirrhosis hospitalized at Indiana University Hospital between November 2015 and October 2018 with a TEG. We examined the relationships among TEG, traditional measures of hemostasis, liver disease severity, and outcomes, including mortality, discharge to hospice, length of stay, and 30-day readmission. A total of 344 patients met inclusion and exclusion criteria. R-value was elevated (≥10 min) in 4.5%, alpha angle was low (<45°) in 9.3%, and maximum amplitude (maximum amplitude) was low (<55 mm) in 72.1%. K-value, alpha angle, and maximum amplitude were all correlated with both platelet count and fibrinogen (absolute rho range 0.52–0.67); R-value and international normalized ratio (INR) were not strongly correlated with traditional measures or TEG, respectively. Patients with bleeding had hypercoagulable profiles, and patients with infection had increased R-value and decreased alpha angle. A total of 35.8% died or were discharged to hospice, and these patients had a greater R-value and smaller alpha angle. However, after adjustment for model for end-stage liver disease (MELD), neither R-value nor alpha angle were associated with discharge outcomes. TEG provides insight into the hemostatic state of patients with cirrhosis beyond that of standard measures of hemostasis. It is associated with liver disease severity and outcomes and may play a role complementary to standard measures of hemostasis in this population.
DOI: 10.7534/j.issn.1009-2137.2015.02.049
发表时间: 2015-04-01
期刊: Zhongguo shi yan xue ye xue za zhi
影响因子: --
作者:
Chen, Guan-Yi;Ou Yang, Xi-Lin;Zhao, Xiao-Zi
通讯作者: Zhao, Xiao-Zi
DOI: 10.1002/rth2.12037
发表时间: 2017-10
影响因子: 4.6
作者:
Hugenholtz GCG;Lisman T;Stravitz RT
通讯作者: Stravitz RT
DOI: 10.1002/hep.29773
发表时间: 2018-06-01
期刊: HEPATOLOGY
影响因子: 13.5
作者:
O'Leary, Jacqueline G.;Reddy, K. Rajender;Bajaj, Jasmohan S.
通讯作者: Bajaj, Jasmohan S.
DOI: 10.1182/blood-2010-02-261891
发表时间: 2010-08-12
期刊: BLOOD
影响因子: 20.3
作者:
Lisman, Ton;Porte, Robert J.
通讯作者: Porte, Robert J.
DOI: 10.1016/0016-5085(90)91167-5
发表时间: 1990-11-01
期刊: GASTROENTEROLOGY
影响因子: 29.4
作者:
MCGILL, DB;RAKELA, J;OTT, BJ
通讯作者: OTT, BJ